Symphony Financial Services Inc. Buys 7,058 Shares of agilon health, inc. (NYSE:AGL)

Symphony Financial Services Inc. raised its holdings in shares of agilon health, inc. (NYSE:AGL) by 44.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,000 shares of the company’s stock after acquiring an additional 7,058 shares during the period. Symphony Financial Services Inc.’s holdings in agilon health were worth $44,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of AGL. JPMorgan Chase & Co. boosted its stake in shares of agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after purchasing an additional 1,083,492 shares during the period. Inspire Investing LLC boosted its stake in shares of agilon health by 106.6% during the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after purchasing an additional 112,241 shares during the period. Citigroup Inc. lifted its stake in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after acquiring an additional 1,941,993 shares during the period. Geode Capital Management LLC lifted its stake in agilon health by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after acquiring an additional 84,889 shares during the period. Finally, Empowered Funds LLC purchased a new stake in agilon health in the fourth quarter worth $97,000.

Analyst Upgrades and Downgrades

AGL has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a research note on Wednesday, February 26th. Barclays dropped their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Sanford C. Bernstein raised their price target on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th. Finally, JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $3.95.

agilon health Stock Up 6.2 %

NYSE AGL opened at $3.17 on Wednesday. The stock’s 50 day moving average is $3.01 and its 200 day moving average is $2.97. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73. The stock has a market cap of $1.30 billion, a PE ratio of -3.37 and a beta of 0.67.

Insider Buying and Selling

In other news, Director Karen Mcloughlin acquired 25,000 shares of agilon health stock in a transaction on Friday, December 13th. The shares were acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the purchase, the director now directly owns 73,166 shares in the company, valued at $160,965.20. The trade was a 51.90 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction on Thursday, December 5th. The stock was purchased at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the purchase, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 77,500 shares of company stock valued at $169,600. Corporate insiders own 3.20% of the company’s stock.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.